Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 30.3B | 30.8B | 32.9B | 34.5B |
Cost of revenue | 29.8B | 30.1B | 32.1B | 33.1B |
Gross profit | 496M | 618M | 744M | 1.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 261M | 266M | 234M | 203M |
Other operating expenses | 4M | 4M | 3M | 3M |
Operating income | 231M | 348M | 507M | 1.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 137M | 135M | 141M | 140M |
Other income expense | -1.0B | 110M | 123M | 122M |
Pretax income | -917M | 323M | 489M | 1.2B |
Tax provision | -265M | -34M | 96M | 277M |
Net income | -652M | 357M | 393M | 926M |
Basic EPS | -1.9 | 0.9 | 1.1 | 2.7 |
Diluted EPS | -1.9 | 0.9 | 1.1 | 2.7 |
Basic average shares | 314M | 315M | 318M | 324M |
Diluted average shares | 314M | 316M | 318M | 324M |
EBITDA | 1.0B | 1.2B | 1.3B | 2.0B |
Net income from continuing op. | -652M | 357M | 393M | 926M |
Minority interests | 57M | -76M | -29M | -46M |
Preferred stock dividends | 1M | 1M | 1M | 3M |